Trial Profile
Phase Ib study of neoadjuvant use of oral phenoxodiol [idronoxil] in patients with primary diagnosis of squamous cell carcinoma or adenocarcinoma of the cervix, vagina or vulva
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 28 Mar 2006
Price :
$35
*
At a glance
- Drugs Idronoxil (Primary)
- Indications Cervical cancer; Vulvovaginal cancer
- Focus Adverse reactions; Therapeutic Use
- 28 Mar 2006 New trial record.